Leukocyte Transcriptional Response in Sepsis.
Leukocyte Transcriptional Response in Sepsis.
复制标题
脓毒症中的白细胞转录反应。
DOI：
10.1097/shk.0000000000001258
复制
发表时间：
2019
期刊：
影响因子：
--
通讯作者：
Shapiro,NathanI
中科院分区：
文献类型：
--
作者：
Skibsted,Simon;Bhasin,ManojK;Henning,DanielJ;Jaminet,ShouChing;Lewandowski,Jeffrey;Kirkegaard,Hans;Aird,WilliamC;Shapiro,NathanI
Background:The complex host response to sepsis is incompletely understood. The aim of this investigation is to use leukocyte RNA sequencing to characterize biological functions, cellular pathways, and key regulatory molecules driving sepsis pathophysiology.Methods:This was a prospective, observational study of emergency department patients with sepsis, at an urban, academic, tertiary care center. In the derivation cohort, we collected blood at enrollment and 90 days after hospital discharge allowing each patient to serve as an internal control. We performed RNA sequencing to quantify transcriptional expression changes during sepsis and non-sepsis states. We then performed unsupervised and supervised analyses, as well as functional and pathway analyses. We selected the top down and upregulated genes and key regulatory molecules for validation. Validation occurred in a cohort of septic and non-septic using real-time PCR.Results:The derivation cohort included 5 patients, and RNA sequencing revealed 916 unique mRNA transcripts differentially expressed during sepsis. Among these, 673 (73%) genes were upregulated, and 243 (27%) were downregulated. Functional enrichment analysis revealed a highly dynamic downstream effect of the transcriptional activity during sepsis. Of the 43 functional cellular pathways activated during sepsis, the top pathways were closely associated with inflammation and response to infection. Validation occurred in 18 septic and 25 non-septic control patients, with 34/45 (76%) of identified genes validated. The regulatory analysis identified several key regulators of sepsis.Conclusions:Highly dynamic transcriptional activity occurs in leukocytes during sepsis, activating key cellular pathways and master regulatory molecules that drive the sepsis process.
